Novel bright-emission small-molecule NIR-II fluorophores for: In vivo tumor imaging and image-guided surgery

262Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

Abstract

Though high brightness and biocompatible small NIR-II dyes are highly desirable in clinical or translational cancer research, their fluorescent cores are relatively limited and their synthetic processes are somewhat complicated. Herein, we have explored the design and synthesis of novel NIR-II fluorescent materials (H1) without tedious chromatographic isolation with improved fluorescence performance (QY ≈ 2%) by introducing 2-amino 9,9-dialkyl-substituted fluorene as a donor into the backbone. Several types of water-soluble and biocompatible NIR-II probes: SXH, SDH, and H1 NPs were constructed via different chemical strategies based on H1, and then their potential to be used in in vivo tumor imaging and image-guided surgery in the NIR-II region was explored. High levels of uptake were obtained for both passive and active tumor targeting probes SXH and SDH. Furthermore, high resolution imaging of blood vessels on tumors and the whole body of living mice using H1 NPs for the first time has demonstrated precise NIR-II image-guided sentinel lymph node (SLN) surgery.

Cite

CITATION STYLE

APA

Sun, Y., Ding, M., Zeng, X., Xiao, Y., Wu, H., Zhou, H., … Hong, X. (2017). Novel bright-emission small-molecule NIR-II fluorophores for: In vivo tumor imaging and image-guided surgery. Chemical Science, 8(5), 3489–3493. https://doi.org/10.1039/c7sc00251c

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free